Program / Reception
January 24
6:30 PM
Luminary and Pioneer Award Reception honoring Roger Perlmutter, Laura Esserman, Irv Weissman and Ralph Snyderman. Different venue with separate registration (req.); send inquiries to [email protected] (space is limited)
Program / Day1
January 25
TRACK 1
7:00 AM
Registration, Breakfast and Networking
7:45 AM
Tal Behar, PMWC Intl
Opening words
7:50 AM
Atul Butte, UCSF
Opening words by program chair
7:55 AM
Euan Ashley, Stanford Health Care
Opening words by co-host
8:05 AM
Sam Hawgood, UCSF
Opening words by co-host
8:15 AM
Robert Califf, FDA
Ralph Snyderman, Duke
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients
Advancing Wellness with Preventative and PM
8:45 AM
Lee Hood, Inst. System Bio.
Clayton Lewis, Arivale
Moderator: Ralph Snyderman, Duke
Launching a New Sector – Scientific Wellness
9:15 AM
Mike Snyder, Stanford
Managing Health Using Personal Omics Profiling
9:30 AM
Brad Perkins, Human Longevity Inc
New Models for Genomics-based Health
9:45 AM
Roger Perlmutter, Merck Research Laboratories
Honoree Keynote
10:00 AM
Break, Exhibition & Networking
Cancer Dx: Transl. Discoveries & Clin. Apps
10:30 AM
Ann Kapoun, OncoMed Pharmaceuticals
Opening by session chair
10:45 AM
Laura Esserman, UCSF
Using Biomarkers and Diagnostics to Impact Care
11:00 AM
Klaus Lindpaintner, Thermo Fisher Scientific
Democratizing Oncology Precision Medicine with NGS
Cancer Dx – Indispensable Products
11:15 AM
Brad Gray, NanoString Tech.
Powering Precision Oncology with 3D Biology
11:30 AM
Jeffrey Miller, Invivoscribe
Clonality & MRD Testing in Clinical Practice
11:45 AM
Ilan Kirsch, Adaptive Biotechnologies
Immunosequencing in the Service of Immune-Oncology
12:00 PM
Matt Franklin, Foundation Medicine
Molecular Decision Support
12:15 PM
Lunch, Exhibition & Networking
Cancer Dx: Transl. Discoveries & Clin. Apps
1:15 PM
John West, Personalis
1:30 PM
Christine Cournoyer, N-of-One
Clinical Interpretation Equals
Patient-specific Analysis
1:45 PM
Sean Scott, Qiagen
Scaling NGS Test Interpretation and Reporting In Oncology
Impact of Patient Data Access
on Oncology Precision Medicine
2:00 PM
Martin Naley, Cure Forward
Opening by session chair
Panel:
Alicia Cornish, U.S. Department of
Health and Human Services
Lisa Holland, McKesson Specialty Health
Jamie Keck, Knight Cancer Inst.
Michael Vinegra, Novartis
Brian Wright, Paradigm Dx
3:00 PM
Break, Exhibition & Networking
Clinical Implementation of PM Programs
3:30 PM
Panel:
Suzanne Belinson, BCBSA
Thomas Brown, Swedish Cancer Institute
Dax Kurbegov, Catholic Health Initiatives
Lincoln Nadauld, Intermountain
Moderator: Jonathan Hirsch, Syapse
Healthcare Information and Management Systems
4:15 PM
Istvan Petak, RealTime Oncology
Learning & Ranking of Treatment Options in Precision Oncology
4:30 PM
Brady Davis, Illumina
Not Just Noise: Transforming Big Data into Smart Data
Fireside Chat
4:45 PM
Roopom Banerjee, RainDance Tech
Alex De Winter, GE Ventures
Tales from the Front Line
5:10 PM
Closing
TRACK 2
NGS And Clinical Interplay
9:00 AM
Panel:
Richard Klausner, Illumina
Klaus Lindpaintner, Thermo Fisher Scientific
Jonas Korlach, PacBio
Stefan Roever, Genia
Peter Yu, PAMF
Moderator: Allison Ballmer, Roche Sequencing
9:45 AM
Cameron Frayling, Base4
Single Molecule Sequencing with Microdroplets
10:00 AM
Break, Exhibition & Networking
Practicing Pathologists in PM
10:30 AM
George Lundberg, Stanford
Opening by session chair
10:45 AM
Steve Miller, UCSF
Precision Diagnosis of Infections by Metagenomic Sequencing
11:00 AM
Kojo Elenitoba-Johnson, UPenn
Novel Actionable Mutations in Cutaneous T-Cell Lymphoma
11:15 AM
Alexander Judkins, CHLA
Pathology Radiology Integration: Emerging Tools for Converging Diagnostics
PM in Organ Transplantation
11:30 AM
John Sninsky, CareDx
Personalized Medicine in Organ Transplantation
11:45 AM
Roy First, Transplant Genomics
Clinical use of Genomic Biomarkers in Transplantation
12:00 PM
Minnie Sarwal, UCSF
The SORT Assay for Diagnosis of Organ Transplant Rejection
12:15 PM
Lunch, Exhibition & Networking
From Biomarkers to Clinical Diagnostics
1:00 PM
Andreas Kogelnik, Open Medicine Institute (OMI)
Omics, Outcomes and Ouchies: Relevant Measurements
1:15 PM
Anna Barker, ASU
Where Have All the
Biomarkers Gone?
1:30 PM
Timothy Triche, CHLA & USC
Diagnostic Potential of Non-coding RNA in Cancer
1:45 PM
Panel
Proteomics and Personalized Medicine: Ongoing Partnership
2:00 PM
Scott Patterson, Gilead
Opening by session chair
2:15 PM
Garry Nolan, Stanford
HiD Cell Barcoding & Imaging
2:30 PM
Jacob Kennedy, Fred Hutchinson
Precision Medicine: One Scientist’s Perspective
2:45 PM
Panel
3:00 PM
Break, Exhibition & Networking
Emerging Company Competition Finals
3:30 PM
Sheldon Schuster, Keck Inst.
Opening words by session chair
Judges:
Zachary Bogue, Data Collective
Isaac Bright, Mérieux Développement
Annie Hazlehurst, Faridan Ventures
David Shaywitz, DNAnexus
3 Finalist companies
Winner to be announced
4:30 PM
Closing
TRACK 3
Neuro Dx
11:15 AM
Ajeet Singh, CNSDose
CNSDose – Genetically Guided Antidepressants
11:30 AM
Craig Shimasaki,
Moleculera Labs
Molecular Mimicry and Infections Causing CNS Disorders
Biomarkers Tech.
11:45 AM
Biana Godin, Houston Methodist RI
Personalization of Tumor Therapy Using Biophysical Markers
12:00 PM
Sol Efroni, Bar Ilan University
BCL2 Variation Determines Chemotherapy Response
12:15 PM
Lunch, Exhibition & Networking
Liquid Biopsy, Technological Advancements
1:00 PM
George Karlin-Neumann, Bio-Rad
Droplet Digital PCR
1:15 PM
Austin So, Toma Biosciences
Genomic Cancer Diagnostic in a Community Hospital
1:30 PM
Katherine Richardson, Transgenomic Inc.
The Use of Multiplexed ICE COLD-PCR Coupled to Multiple Downstream Analysis Platforms
1:45 PM
Matthew Hill, Natera
Detection of SNVs and CNVs in ctDNA using Massively-Multiplexed PCR
Liquid Biospy, Clinical Testing Applications
2:00 PM
Frederic Pla, Genomic Health
Liquid Biopsies in the Management of Cancer
2:15 PM
Nicholas Dracopoli,
Janssen R&D
cfDNA or CTCs: Which is Better?
2:30 PM
Michael Nall, Biocept
Completing the Answer in Oncology
2:45 PM
Thomas Krahn, Bayer
CTCs: Capturing, Cultivation and Molecular Analysis
3:00 PM
Break, Exhibition & Networking
Liquid Biospy, Clinical Testing Applications- Cont.
3:30 PM
Vincent O’Neill, Exosome Diagnostics
Exosomal RNA-based Liquid Biopsies: Why cfDNA Alone is Not Sufficient for Non-invasive Genotyping
3:45 PM
Cristian Ionescu-Zanetti, Fluxion Bio.
Fluxion’s Liquid Biopsy Solution
4:00 PM
Closing
TRACK 4
10:00 AM
Break, Exhibition & Networking
Company Competition: Semi-finals
10:30 AM
Andrew Kurtz, NCI SBIR
NIH Expands I-Corps for SBIR Grantees
10:45 AM
Aldatu Biosciences
11:00 AM
Atomo Diagnostics
11:15 AM
Episona
11:30 AM
HealthMyne
11:45 AM
ImaginAb
12:00 PM
Lunch, Exhibition & Networking
Company Competition Semi-finals – Cont.
1:00 PM
Inivata
1:15 PM
Mindera
1:45 PM
Vortex Biosciences
2:00 PM
Xcell Biosciences
2:15 PM
Break
Investments in PM: What to Consider
2:30 PM
Matthew Cooper, Progenity
Seed Round to Exit in 18 Months: Lessons Learned from Carmenta Bioscience
2:45 PM
Brian Bock, JMP Securities
Capital Markets & M&A Trends
3:00 PM
Break, Exhibition & Networking
PM and Diagnostics Beyond the USA
3:30 PM
Anders Colver, European Commission
Personalised Medicine: A Priority for Europe
3:45 PM
Mara Aspinall, EPEMED
4:00 PM
Closing
Program / Day2
January 26
TRACK 1
7:00 AM
Registration, Breakfast and Networking
7:25 AM
Edward Abrahams, PMC
Opening words
7:30 AM
Sheila Walcoff, Goldbug Strategies LLC
More Shades of Gray? FDA Compliance After
Pathway and Theranos
7:45 AM
Kathy Giusti, MMRF
Precision Oncology — Challenges, Opportunities, Models
Why Biobanking?
8:00 AM
Joe Vockley, Inova
Good Biobanking Is Hard
8:15 AM
Catherine Schaefer, Kaiser
Research Biobanking in a Health Care Delivery System
8:30 AM
Sir Rory Collins, UK Biobank
UK Biobank: Resource for
Genetic-epidemiological Research
Knowledge Within Healthcare Data For PM
8:45 AM
Diane Wuest, GNS Healthcare
Multimodal Data Analytics Accelerate Actionable Insights
Data-Driven Rx & Dx
9:00 AM
Atul Butte, UCSF
Opening words by session chair
9:15 AM
Asim Siddiqui, NuMedii
Turning Big Data into Smart Data
9:30 AM
Slava Akmaev, Berg
Artificial Intelligence in Drug Development: Case Studies
9:45 AM
Panel
10:00 AM
Break, Exhibition & Networking
Data Solutions in Clinical Genomics
10:30 AM
David Haussler, UCSC
Opening words by session chair
10:40 AM
Panel
Jonathan Sheldon, Oracle
Carlos Bustamante, Stanford
Taylor Sittler, Color Genomics
Moderator: David Haussler, UCSC
Generating Data-Driven Insight in Personalized Medicine Programs
11:30 AM
Panel:
Mathias Ehrich, Sequenom
Tyler Wish, Sequence Bio
Aaron Black, Inova
Moderator: Mick Correll, Genospace
11:45 AM
Panel Continues
12:15 PM
Lunch, Exhibition & Networking
Generating Data-Driven
Insight- Cont.
1:00 PM
Janusz Dutkowski, Data4Cure
Learning As We Go: Updating
Biomedical Knowledge From Data
Genome: Silos, Hacking Privacy, Collab.
1:15 PM
Somalee Datta, Stanford
Opening words by session chair
1:30 PM
Philip Tsao, VA Palo Alto
The VA Million Veterans Program
1:45 PM
William Knox Carey, Intertrust Tech
Access vs Privacy: A False Dichotomy
2:00 PM
Panel
Patient Experience
2:15 PM
John Steiner, CTCA
Opening words by session chair
2:30 PM
Panel
Christine Bray, Patient
Richard Schilsky, ASCO
John Steiner, CTCA
Moderator:
Maurie Markman, CTCA
3:00 PM
Panel Continues
3:15 PM
Break, Exhibition & Networking
Reimbursement Challenges
and Solutions
3:30 PM
Rina Wolf, XIFIN
Opening words by session chair
3:45 PM
Girish Putcha, Palmetto GBA
MolDX 2016: Updates and Lessons Learned
4:00 PM
Amber Trivedi, InformedDNA
Different Perspectives, Common Goals: Getting Stakeholders Aligned
4:15 PM
Panel
Stem Cell Research
4:30 PM
Irv Weissman, Stanford
Normal and Cancer Stem
Cells: Biology and
Translation
4:50 PM
Closing
TRACK 2
Diagnosis & Management of Rare Disease
8:00 AM
Patrice Milos, Claritas Genomics
Opening words by session chair
8:15 AM
Sharon Terry, Genetic Alliance
Speaking of Rare Diseases:
Transforming the Paradigm
8:30 AM
Timothy Yu, Boston Children’s Hospital
A Holistic Approach to Research and Clinical Care in Pediatric Rare Disease
8:45 AM
Albert Seymour, Shire Pharm.
Unique Challenges to Discover and Develop Novel Therapeutics
Biomarkers for Autoimmune Disease
9:00 AM
Eric Sasso, Crescendo Bioscience
Opening words by session chair
9:15 AM
Mike Townsend, Genentech
Disease Heterogeneity and Drug Response in Rheumatoid Arthritis
9:30 AM
William Hewitt Robinson, Stanford
Sequencing Antibody Repertoires in RA
9:45 AM
Panel
10:00 AM
Break, Exhibition & Networking
Noninvasive Liquid Biopsies for Cancer Patients
10:30 AM
Walter Koch, Roche Dx
Opening words by session chair
10:45 AM
Luis Alberto Diaz, Johns Hopkins
Liquid Biopsy Approaches for Characterizing Cancer Genomes
11:00 AM
Maximilian Diehn, Stanford
Analysis of Circulating Tumor DNA for Personalized Cancer Detection and Monitoring
11:15 AM
Panel
Commercial Applications in Liquid Biopsy
11:30 AM
David Spetzler, Caris Life Sciences
Protein-complexes on Exosomes Enable Liquid Biopsy
11:45 AM
Roopom Banerjee, RainDance Tech
Why Technology Matters for Commercialization and Adoption
12:00 PM
Paul Y. Song, Cynvenio
Liquid Biopsy in Immunotherapy and Beyond
12:15 PM
Lunch, Exhibition & Networking
Liquid Biopsy – Using the Right Tool for the Right Job
1:00 PM
Murali Prahalad, Epic Sciences
Liquid Biopsy – Using the Right Tool for the Right Job
1:15 PM
Helmy Eltoukhy, Guardant Health
Cancer’s Tweet: 160bp Snapshots into Cancer’s Hidden Evolution
1:30 PM
Mark Erlander, Trovagene
Revolutionizing Cancer Care with Urine ctDNA
1:45 PM
Panel
2:00 PM
Phil Stephens, Foundation Medicine
CtDNA Guides Therapeutic Decisions for Cancer Patients. FACT or FICTION?
2:15 PM
Jean-Francois Laes, OncoDNA
Liquid biopsy in One Clinical’s Patient Trial Paradigm
Genetics Informed Personalized Immunotherapy
2:30 PM
Patrick Roche, HTG
Opening words by session chair
2:45 PM
Patrice Hugo, Q2 Solutions
Genomics Enhances Clinical Immuno-oncology Trials
3:00 PM
Cariad Chester, Stanford
Immunomodulation of Natural Killer Cells
3:15 PM
Panel
3:30 PM
Break, Exhibition & Networking
Metabolomics and Its Role in the Movement Towards PM
3:45 PM
John Ryals, Metabolon Inc.
Opening words by session chair
4:00 PM
Andreas Kogelnik, Open Medicine Institute (OMI)
Metabolomic Profiling – Leading Towards the Elucidation of Disease
4:15 PM
Deaunne Denmark, Metabolon Inc.
A Patient Journey
4:30 PM
Panel
4:45 PM
Closing
TRACK 3
Podium Present.
Genome Data Analysis & Mgmt.
8:45 AM
Mohamood Adhil, IntepretOmics
Omics-based (CDx)-drug-(Rx) Solution
9:00 AM
Alex Dickinson, Illumina
Data Challenges in Nation-Scale Sequencing Projects
9:15 AM
Ingrid Slade, Oxford Univ.
Collecting Genomic Data – Is a New Ethical Approach Required?
9:30 AM
Pieter van Rooyen, Edico
Janis Landry-Lane, IBM
Joint Presentation: The Turnkey Genomics Compute and Storage Solution
9:45 AM
Dvir Dahary, LifeMap Sciences
TGex: NGS Analysis Made Simple
10:00 AM
Break, Exhibition & Networking
Synthetic Biology’s Rise in PM
10:30 AM
Sanjay Joshi, EMC Isilon
2015 Synthetic Biology Roundup
10:45 AM
Geraldine Hamilton,
Emulate Inc.
Organs-On-Chips for Advancing Precision
Medicine
11:00 AM
Clive Svendsen,
Cedars-Sinai Medical Center
Personalized Medicine Using iPSCs and Organs-on-Chips
11:15 AM
Patrick Finn, Twist Biosciences
Rewriting DNA Synthesis
CRISPR-G-editing
11:30 AM
Jacob Corn, UC Berkeley
Gene Correction with CRISPR-Cas9
Immune Cell Therapy
11:45 AM
David Martin, AvidBiotics
MicAbody™ Proteins Engage NK- and T-Cells
12:00 PM
Lunch, Exhibition & Networking
New Approaches
in Cancer Dx
1:00 PM
Marc Grodman, BioReference Laboratories A New Model of Clinical Genomics Collaboration
1:15 PM
Anne-Renee Hartman, Myriad
Integrated Genomic Platform for Companion Diagnostics
1:30 PM
Eric Rowinsky, Mitra Biotech
Systems Biology Approach to Predicting Response to Cancer Therapeutics
1:45 PM
Josh Stahl, ArcherDx
Complex Variant Detection Using Anchored Multiplex PCR
New Ways in Profiling Cancer
2:00 PM
Hawazin Faruki,
Genecentric
Genomic Tumor Proflling – Advancing Beyond Gene Mutations
2:15 PM
Jerry Parrott, BioMarker Strategies
Functional Profiling to Guide Cancer Drug Development and Treatment Selection
2:30 PM
Neil Campbell, Helomics
Comprehensive Tumor Profiling: Its more than Genes
2:45 PM
Russell Garlick, SeraCare Life Sciences
NGS Presents New Quality Control Challenges
3:00 PM
Break, Exhibition & Networking
3:30 PM
Closing
TRACK 4
Podium Present.
Next Generation Tools
8:45 AM
Fred Streitz, LLNL
Towards Predictive Biology with Extreme Scale Computing
9:00 AM
Bharath Takulapalli, INanoBio
Developing High Accuracy Nanopore Sequencer for $100 Genome
9:15 AM
Peter Pmaneus, Imec
Miniaturized Instrumentation to Enable Personalized Medicine
Pathogen Dx
9:30 AM
Leo McHugh, Immunexpress
Infectious Disease Diagnosis Using SeptiCyte® Gene Sign.
9:45 AM
Charles Chiu, UCSF
Genomic Approaches for Pathogen and Infectious Disease Diagnosis
10:00 AM
Break, Exhibition & Networking
Genomic Centers
10:30 AM
Ketan Paranjape, Intel
Opening words by session chair
10:45 AM
Patricia Kovatch, Icahn School of Medicine at Mount Sinai
11:00 AM
Tim Cutts, Sanger Inst.
11:15 AM
Chris Dwan, Broad Inst.
11:30 AM
Mark Beggs, Stratified Medicine Scotland
Engaging a Country for Precision Medicine
11:45 AM
John Witte, UCSF Institute for Human Genetics
12:00 PM
Lunch, Exhibition & Networking
Sequencing Platforms
1:00 PM
Jonas Korlach, PacBio
Whole Genome? The Future of High-Quality, De Novo Human Genomes
Clinically Useful Genome Interpretation
1:30 PM
Edmund Tai, PAMF
Germline Testing for Hereditary Cancer
1:45 PM
Nathan Pearson, NYGC
Why We Should Classify Genotypes, Not Variants
2:00 PM
Panel
Unlocking Data to Advance PM
2:15 PM
Pek Lum, Capella Bio
Precise Medicines from Data
2:30 PM
Bryce Olson, Intel
Collaborative Cancer Care: Unlocking Data
2:45 PM
Panel
3:00 PM
Break, Exhibition & Networking
Petabyte Scale Genomics:
Using Big Metal to Study Big Cohorts
4:00 PM
Frank Austin Nothaft, UC Berkeley AMPLab
4:15 AM
Cuiping Pan, VA Palo Alto
4:30 PM
Mike Lin, DNAnexus
4:45 PM
Uri Laserson, Cloudera
5:00 PM
Closing
Program / Day3
January 27
TRACK 1
7:00 AM
Registration, Breakfast and Networking
The Give and Take Between
Government & Personalized Medicine
8:00 AM
Kathy Hudson, NIH
The President’s Precision Medicine Initiative®
8:15 AM
Atul Butte, UCSF
The Give and Take Between
Government & Personalized Medicine
8:30 AM
Elizabeth Baca, Governor Jerry Brown’s Office of Planning and Research (OPR)
The Observation of Accelerated Transformation of Biomedicine
8:45 AM
Keith Yamamoto, UCSF
Precision Medicine: Beyond The Inflection Point
Patient-centered Drug Development
9:00 AM
Stephan Brock, Molecular Health
Clinical Innovation Using Outcomes Data
9:15 AM
Mark L. Watson, Guardian Research Network
Re-Engineering The US Clinical Trials System
9:30 AM
Alan Wu, UCSF
Promoting Pharmacogenomics to the Public
9:45 AM
Panel
10:00 AM
Break, Exhibition & Networking
New Drug Discovery in Oncology: Faster, Cheaper, Better
10:30 AM
George Sledge, Stanford
Opening words by session chair
10:45 AM
Gideon Blumenthal, FDA
Expediting Development of Oncology Drugs
11:00 AM
August Salvado, Novartis
Signature: Designed to Find the Right Patient
11:15 AM
Panel
Personalized Medicine Patent Law Update
11:30 AM
Catherine Polizzi, Morrison & Foerster
Michael Shuster, Fenwick & West
12:00 PM
Q&A
12:15 PM
Lunch, Exhibition & Networking
Expansion of Non-Invasive Prenatal Testing
1:00 PM
Kimberly Martin, Natera
Opening by session chair
1:15 PM
Peter Benn, UConn Health
Non-invasive Testing for Low-risk Women
1:30 PM
Anthony Gregg, UF
Disruption the Nidus for Practice Guideline Development
1:45 PM
Panel
The Microbiome- A Modifiable Biomarker?
2:00 PM
Ami Bhatt, Stanford
Opening words by session chair
2:15 PM
Peter DiLaura, Second Genome
Exploring the Microbiome for Novel Therapeutics
2:30 PM
David Cook, Seres Therapeutics
Microbiome Therapeutics in The Age of Personalized DNA
Sequence
2:45 PM
Panel
3:00 PM
Break, Exhibition & Networking
Changing the
Point Of Care Setting
3:30 PM
Charles Chiu, UCSF
Changing the Point-of-Care Setting for Precision Medicine in Infectious Diseases
4:00PM
Closing
TRACK 2
8:15 AM
Mara Aspinall, GenePeeks
The Role of Algorithms in Clinical Diagnostics
Large-scale Genomics Projects
8:30 AM
David Ledbetter, Geisinger
Geisinger’s Precision Health Initiative
8:45AM
Peter Donnelly, Oxford University
Using Genetics to Improve Healthcare
9:00 AM
Andrew Carroll, DNAnexus
Genomics in the Next Five Years
9:15 AM
Hannes Smarason, WuXi NextCODE
Delivering Precision Medicine Worldwide Today
9:30 AM
Catherine Ball, Ancestry
Genomic Data, Migration Patterns & Disease
9:40 AM
Panel
10:00 AM
Break, Exhibition & Networking
Large Scale Sequencing and Analysis
10:30 AM
David Glazer, Google
Opening words by session chair
10:45 AM
Jurgi Camblong, Sophia Genetics
Towards Data Driven Medicine:
Europe Shows the Way
11:00 AM
Devin Locke,
Seven Bridges Genomics
Discovery in Millions of Genomes
11:15 AM
Panel
Consumer Genomics
11:30 AM
Justin Kao, Helix
Helix: A New Approach to Consumer Genomics
11:45 AM
Break
12:00 PM
Lunch, Exhibition & Networking
Expediting Genomics into the Clinic
1:00 PM
Lincoln Nadauld, Intermountain Healthcare
Opening words by session chair
1:15 PM
Sherri Millis, Ashion Analytics
Go Big or Go Home
1:30 PM
James Ford, Stanford
Implementing a Clinical Cancer Genomics Program
1:45 PM
Panel
Producing Clinical Actionable Reports
2:00 PM
Sean Sigmon, Oracle
Scaling & Enhancing PM Reporting
2:15 PM
Don Rule, Translational Software
Big Data to Actionable Reports
2:30 PM
Shaun Opie, Vantari Genetics
Bootstrapping Clinically Actionable Reports
2:45 PM
Panel
3:00 PM
Break, Exhibition & Networking
Early Cancer Detection: A new Hope
3:30PM
Raghu Kalluri,
MD Anderson
Utility Of Exosomes in the Detection of Cancer
4:00PM
Closing
TRACK 3
Genomics Offered As-a-Service
9:45 AM
Taylor Sittler, Color Genomics
Responsible Genetic Testing at Color Genomics
10:00 AM
Break, Exhibition & Networking
Precision Medicine in the Clinical Workflow
10:30 AM
Assaf Halevy, Allscripts
Precision Medicine in the Clinical Workflow
10:45 AM
Mark Harris, NextGxDx
Efficiency and Transparency in Genetic Diagnostics
Innovation Advances in NIPT
11:00 AM
Gautam Kollu, Illumina
Innovative Advances in Non-Invasive Prenatal Testing
11:15 AM
Mathias Ehrich, Sequenom
Expanding NIPT to the Whole Genome
11:30 AM
Lee Shulman, Northwestern University
CCFNA: Improving Prenatal Screening & Beyond
11:45 AM
Panel
12:00 PM
Lunch, Exhibition & Networking
Carrier and Hereditary Disease Testing
1:00 PM
Ramji Srinivasan, Counsyl
Opening by session chair
Panel:
Emily Rapp Black, Patient
Ruth Bunker Lathi, Stanford
Ramji Srinivasan, Counsyl
Carrier and Hereditary Disease Testing- Cont.
2:00 PM
Tero-Pekka Alastalo, Blueprint Genetics Inc.
OS-Seq Boosting Genetic Diagnostics
2:15 PM
Alexander Bisignano, Recombine
Powering Research Through the Clinic
Obesity & Diabetes
2:30 PM
Robert Lustig, UCSF
Genes & Environment in Metabolic Disease
2:45 PM
Ruth March, Astra Zeneca
Personalised Healthcare in Metabolic Disease
3:00 PM
Break, Exhibition & Networking
3:30 PM
Closing
Program / Reception
January 24
6:30 PM
Luminary and Pioneer Award Reception honoring Roger Perlmutter, Laura Esserman, Irv Weissman and Ralph Snyderman. Different venue with separate registration (req.); send inquiries to [email protected] (space is limited)
Program / Day1
January 25
TRACK 1
7:00 AM
Registration, Breakfast and Networking
7:45 AM
Tal Behar, PMWC Intl
Opening words
7:50 AM
Atul Butte, UCSF
Opening words by program chair
7:55 AM
Euan Ashley, Stanford Health Care
Opening words by co-host
8:05 AM
Sam Hawgood, UCSF
Opening words by co-host
8:15 AM
Robert Califf, FDA
Ralph Snyderman, Duke
Fireside Chat: FDA’s Role and Responsibility in Expediting Best Treatments for Patients
Advancing Wellness with Preventative and PM
8:45 AM
Lee Hood, Inst. System Bio.
Clayton Lewis, Arivale
Moderator: Ralph Snyderman, Duke
Launching a New Sector – Scientific Wellness
9:15 AM
Mike Snyder, Stanford
Managing Health Using Personal Omics Profiling
9:30 AM
Brad Perkins, Human Longevity Inc
New Models for Genomics-based Health
9:45 AM
Roger Perlmutter, Merck Research Laboratories
Honoree Keynote
10:00 AM
Break, Exhibition & Networking
Cancer Dx: Transl. Discoveries & Clin. Apps
10:30 AM
Ann Kapoun, OncoMed Pharmaceuticals
Opening by session chair
10:45 AM
Laura Esserman, UCSF
Using Biomarkers and Diagnostics to Impact Care
11:00 AM
Klaus Lindpaintner, Thermo Fisher Scientific
Democratizing Oncology Precision Medicine with NGS
Cancer Dx – Indispensable Products
11:15 AM
Brad Gray, NanoString Tech.
Powering Precision Oncology with 3D Biology
11:30 AM
Jeffrey Miller, Invivoscribe
Clonality & MRD Testing in Clinical Practice
11:45 AM
Ilan Kirsch, Adaptive Biotechnologies
Immunosequencing in the Service of Immune-Oncology
12:00 PM
Matt Franklin, Foundation Medicine
Molecular Decision Support
12:15 PM
Lunch, Exhibition & Networking
Cancer Dx: Transl. Discoveries & Clin. Apps
1:15 PM
John West, Personalis
1:30 PM
Christine Cournoyer, N-of-One
Clinical Interpretation Equals
Patient-specific Analysis
1:45 PM
Sean Scott, Qiagen
Scaling NGS Test Interpretation and Reporting In Oncology
Impact of Patient Data Access
on Oncology Precision Medicine
2:00 PM
Martin Naley, Cure Forward
Opening by session chair
Panel:
Alicia Cornish, U.S. Department of
Health and Human Services
Lisa Holland, McKesson Specialty Health
Jamie Keck, Knight Cancer Inst.
Michael Vinegra, Novartis
Brian Wright, Paradigm Dx
3:00 PM
Break, Exhibition & Networking
Clinical Implementation of PM Programs
3:30 PM
Panel:
Suzanne Belinson, BCBSA
Thomas Brown, Swedish Cancer Institute
Dax Kurbegov, Catholic Health Initiatives
Lincoln Nadauld, Intermountain
Moderator: Jonathan Hirsch, Syapse
Healthcare Information and Management Systems
4:15 PM
Istvan Petak, RealTime Oncology
Learning & Ranking of Treatment Options in Precision Oncology
4:30 PM
Brady Davis, Illumina
Not Just Noise: Transforming Big Data into Smart Data
Fireside Chat
4:45 PM
Roopom Banerjee, RainDance Tech
Alex De Winter, GE Ventures
Tales from the Front Line
5:10 PM
Closing
TRACK 2
NGS And Clinical Interplay
9:00 AM
Panel:
Richard Klausner, Illumina
Klaus Lindpaintner, Thermo Fisher Scientific
Jonas Korlach, PacBio
Stefan Roever, Genia
Peter Yu, PAMF
Moderator: Allison Ballmer, Roche Sequencing
9:45 AM
Cameron Frayling, Base4
Single Molecule Sequencing with Microdroplets
10:00 AM
Break, Exhibition & Networking
Practicing Pathologists in PM
10:30 AM
George Lundberg, Stanford
Opening by session chair
10:45 AM
Steve Miller, UCSF
Precision Diagnosis of Infections by Metagenomic Sequencing
11:00 AM
Kojo Elenitoba-Johnson, UPenn
Novel Actionable Mutations in Cutaneous T-Cell Lymphoma
11:15 AM
Alexander Judkins, CHLA
Pathology Radiology Integration: Emerging Tools for Converging Diagnostics
PM in Organ Transplantation
11:30 AM
John Sninsky, CareDx
Personalized Medicine in Organ Transplantation
11:45 AM
Roy First, Transplant Genomics
Clinical use of Genomic Biomarkers in Transplantation
12:00 PM
Minnie Sarwal, UCSF
The SORT Assay for Diagnosis of Organ Transplant Rejection
12:15 PM
Lunch, Exhibition & Networking
From Biomarkers to Clinical Diagnostics
1:00 PM
Andreas Kogelnik, Open Medicine Institute (OMI)
Omics, Outcomes and Ouchies: Relevant Measurements
1:15 PM
Anna Barker, ASU
Where Have All the
Biomarkers Gone?
1:30 PM
Timothy Triche, CHLA & USC
Diagnostic Potential of Non-coding RNA in Cancer
1:45 PM
Panel
Proteomics and Personalized Medicine: Ongoing Partnership
2:00 PM
Scott Patterson, Gilead
Opening by session chair
2:15 PM
Garry Nolan, Stanford
HiD Cell Barcoding & Imaging
2:30 PM
Jacob Kennedy, Fred Hutchinson
Precision Medicine: One Scientist’s Perspective
2:45 PM
Panel
3:00 PM
Break, Exhibition & Networking
Emerging Company Competition Finals
3:30 PM
Sheldon Schuster, Keck Inst.
Opening words by session chair
Judges:
Zachary Bogue, Data Collective
Isaac Bright, Mérieux Développement
Annie Hazlehurst, Faridan Ventures
David Shaywitz, DNAnexus
3 Finalist companies
Winner to be announced
4:30 PM
Closing
TRACK 3
Neuro Dx
11:15 AM
Ajeet Singh, CNSDose
CNSDose – Genetically Guided Antidepressants
11:30 AM
Craig Shimasaki,
Moleculera Labs
Molecular Mimicry and Infections Causing CNS Disorders
Biomarkers Tech.
11:45 AM
Biana Godin, Houston Methodist RI
Personalization of Tumor Therapy Using Biophysical Markers
12:00 PM
Sol Efroni, Bar Ilan University
BCL2 Variation Determines Chemotherapy Response
12:15 PM
Lunch, Exhibition & Networking
Liquid Biopsy, Technological Advancements
1:00 PM
George Karlin-Neumann, Bio-Rad
Droplet Digital PCR
1:15 PM
Austin So, Toma Biosciences
Genomic Cancer Diagnostic in a Community Hospital
1:30 PM
Katherine Richardson, Transgenomic Inc.
The Use of Multiplexed ICE COLD-PCR Coupled to Multiple Downstream Analysis Platforms
1:45 PM
Matthew Hill, Natera
Detection of SNVs and CNVs in ctDNA using Massively-Multiplexed PCR
Liquid Biospy, Clinical Testing Applications
2:00 PM
Frederic Pla, Genomic Health
Liquid Biopsies in the Management of Cancer
2:15 PM
Nicholas Dracopoli,
Janssen R&D
cfDNA or CTCs: Which is Better?
2:30 PM
Michael Nall, Biocept
Completing the Answer in Oncology
2:45 PM
Thomas Krahn, Bayer
CTCs: Capturing, Cultivation and Molecular Analysis
3:00 PM
Break, Exhibition & Networking
Liquid Biospy, Clinical Testing Applications- Cont.
3:30 PM
Vincent O’Neill, Exosome Diagnostics
Exosomal RNA-based Liquid Biopsies: Why cfDNA Alone is Not Sufficient for Non-invasive Genotyping
3:45 PM
Cristian Ionescu-Zanetti, Fluxion Bio.
Fluxion’s Liquid Biopsy Solution
4:00 PM
Closing
TRACK 4
10:00 AM
Break, Exhibition & Networking
Company Competition: Semi-finals
10:30 AM
Andrew Kurtz, NCI SBIR
NIH Expands I-Corps for SBIR Grantees
10:45 AM
Aldatu Biosciences
11:00 AM
Atomo Diagnostics
11:15 AM
Episona
11:30 AM
HealthMyne
11:45 AM
ImaginAb
12:00 PM
Lunch, Exhibition & Networking
Company Competition Semi-finals – Cont.
1:00 PM
Inivata
1:15 PM
Mindera
1:45 PM
Vortex Biosciences
2:00 PM
Xcell Biosciences
2:15 PM
Break
Investments in PM: What to Consider
2:30 PM
Matthew Cooper, Progenity
Seed Round to Exit in 18 Months: Lessons Learned from Carmenta Bioscience
2:45 PM
Brian Bock, JMP Securities
Capital Markets & M&A Trends
3:00 PM
Break, Exhibition & Networking
PM and Diagnostics Beyond the USA
3:30 PM
Anders Colver, European Commission
Personalised Medicine: A Priority for Europe
3:45 PM
Mara Aspinall, EPEMED
4:00 PM
Closing
Program / Day2
January 26
TRACK 1
7:00 AM
Registration, Breakfast and Networking
7:25 AM
Edward Abrahams, PMC
Opening words
7:30 AM
Sheila Walcoff, Goldbug Strategies LLC
More Shades of Gray? FDA Compliance After
Pathway and Theranos
7:45 AM
Kathy Giusti, MMRF
Precision Oncology — Challenges, Opportunities, Models
Why Biobanking?
8:00 AM
Joe Vockley, Inova
Good Biobanking Is Hard
8:15 AM
Catherine Schaefer, Kaiser
Research Biobanking in a Health Care Delivery System
8:30 AM
Sir Rory Collins, UK Biobank
UK Biobank: Resource for
Genetic-epidemiological Research
Knowledge Within Healthcare Data For PM
8:45 AM
Diane Wuest, GNS Healthcare
Multimodal Data Analytics Accelerate Actionable Insights
Data-Driven Rx & Dx
9:00 AM
Atul Butte, UCSF
Opening words by session chair
9:15 AM
Asim Siddiqui, NuMedii
Turning Big Data into Smart Data
9:30 AM
Slava Akmaev, Berg
Artificial Intelligence in Drug Development: Case Studies
9:45 AM
Panel
10:00 AM
Break, Exhibition & Networking
Data Solutions in Clinical Genomics
10:30 AM
David Haussler, UCSC
Opening words by session chair
10:40 AM
Panel
Jonathan Sheldon, Oracle
Carlos Bustamante, Stanford
Taylor Sittler, Color Genomics
Moderator: David Haussler, UCSC
Generating Data-Driven Insight in Personalized Medicine Programs
11:30 AM
Panel:
Mathias Ehrich, Sequenom
Tyler Wish, Sequence Bio
Aaron Black, Inova
Moderator: Mick Correll, Genospace
11:45 AM
Panel Continues
12:15 PM
Lunch, Exhibition & Networking
Generating Data-Driven
Insight- Cont.
1:00 PM
Janusz Dutkowski, Data4Cure
Learning As We Go: Updating
Biomedical Knowledge From Data
Genome: Silos, Hacking Privacy, Collab.
1:15 PM
Somalee Datta, Stanford
Opening words by session chair
1:30 PM
Philip Tsao, VA Palo Alto
The VA Million Veterans Program
1:45 PM
William Knox Carey, Intertrust Tech
Access vs Privacy: A False Dichotomy
2:00 PM
Panel
Patient Experience
2:15 PM
John Steiner, CTCA
Opening words by session chair
2:30 PM
Panel
Christine Bray, Patient
Richard Schilsky, ASCO
John Steiner, CTCA
Moderator:
Maurie Markman, CTCA
3:00 PM
Panel Continues
3:15 PM
Break, Exhibition & Networking
Reimbursement Challenges
and Solutions
3:30 PM
Rina Wolf, XIFIN
Opening words by session chair
3:45 PM
Girish Putcha, Palmetto GBA
MolDX 2016: Updates and Lessons Learned
4:00 PM
Amber Trivedi, InformedDNA
Different Perspectives, Common Goals: Getting Stakeholders Aligned
4:15 PM
Panel
Stem Cell Research
4:30 PM
Irv Weissman, Stanford
Normal and Cancer Stem
Cells: Biology and
Translation
4:50 PM
Closing
TRACK 2
Diagnosis & Management of Rare Disease
8:00 AM
Patrice Milos, Claritas Genomics
Opening words by session chair
8:15 AM
Sharon Terry, Genetic Alliance
Speaking of Rare Diseases:
Transforming the Paradigm
8:30 AM
Timothy Yu, Boston Children’s Hospital
A Holistic Approach to Research and Clinical Care in Pediatric Rare Disease
8:45 AM
Albert Seymour, Shire Pharm.
Unique Challenges to Discover and Develop Novel Therapeutics
Biomarkers for Autoimmune Disease
9:00 AM
Eric Sasso, Crescendo Bioscience
Opening words by session chair
9:15 AM
Mike Townsend, Genentech
Disease Heterogeneity and Drug Response in Rheumatoid Arthritis
9:30 AM
William Hewitt Robinson, Stanford
Sequencing Antibody Repertoires in RA
9:45 AM
Panel
10:00 AM
Break, Exhibition & Networking
Noninvasive Liquid Biopsies for Cancer Patients
10:30 AM
Walter Koch, Roche Dx
Opening words by session chair
10:45 AM
Luis Alberto Diaz, Johns Hopkins
Liquid Biopsy Approaches for Characterizing Cancer Genomes
11:00 AM
Maximilian Diehn, Stanford
Analysis of Circulating Tumor DNA for Personalized Cancer Detection and Monitoring
11:15 AM
Panel
Commercial Applications in Liquid Biopsy
11:30 AM
David Spetzler, Caris Life Sciences
Protein-complexes on Exosomes Enable Liquid Biopsy
11:45 AM
Roopom Banerjee, RainDance Tech
Why Technology Matters for Commercialization and Adoption
12:00 PM
Paul Y. Song, Cynvenio
Liquid Biopsy in Immunotherapy and Beyond
12:15 PM
Lunch, Exhibition & Networking
Liquid Biopsy – Using the Right Tool for the Right Job
1:00 PM
Murali Prahalad, Epic Sciences
Liquid Biopsy – Using the Right Tool for the Right Job
1:15 PM
Helmy Eltoukhy, Guardant Health
Cancer’s Tweet: 160bp Snapshots into Cancer’s Hidden Evolution
1:30 PM
Mark Erlander, Trovagene
Revolutionizing Cancer Care with Urine ctDNA
1:45 PM
Panel
2:00 PM
Phil Stephens, Foundation Medicine
CtDNA Guides Therapeutic Decisions for Cancer Patients. FACT or FICTION?
2:15 PM
Jean-Francois Laes, OncoDNA
Liquid biopsy in One Clinical’s Patient Trial Paradigm
Genetics Informed Personalized Immunotherapy
2:30 PM
Patrick Roche, HTG
Opening words by session chair
2:45 PM
Patrice Hugo, Q2 Solutions
Genomics Enhances Clinical Immuno-oncology Trials
3:00 PM
Cariad Chester, Stanford
Immunomodulation of Natural Killer Cells
3:15 PM
Panel
3:30 PM
Break, Exhibition & Networking
Metabolomics and Its Role in the Movement Towards PM
3:45 PM
John Ryals, Metabolon Inc.
Opening words by session chair
4:00 PM
Andreas Kogelnik, Open Medicine Institute (OMI)
Metabolomic Profiling – Leading Towards the Elucidation of Disease
4:15 PM
Deaunne Denmark, Metabolon Inc.
A Patient Journey
4:30 PM
Panel
4:45 PM
Closing
TRACK 3
Podium Present.
Genome Data Analysis & Mgmt.
8:45 AM
Mohamood Adhil, IntepretOmics
Omics-based (CDx)-drug-(Rx) Solution
9:00 AM
Alex Dickinson, Illumina
Data Challenges in Nation-Scale Sequencing Projects
9:15 AM
Ingrid Slade, Oxford Univ.
Collecting Genomic Data – Is a New Ethical Approach Required?
9:30 AM
Pieter van Rooyen, Edico
Janis Landry-Lane, IBM
Joint Presentation: The Turnkey Genomics Compute and Storage Solution
9:45 AM
Dvir Dahary, LifeMap Sciences
TGex: NGS Analysis Made Simple
10:00 AM
Break, Exhibition & Networking
Synthetic Biology’s Rise in PM
10:30 AM
Sanjay Joshi, EMC Isilon
2015 Synthetic Biology Roundup
10:45 AM
Geraldine Hamilton,
Emulate Inc.
Organs-On-Chips for Advancing Precision
Medicine
11:00 AM
Clive Svendsen,
Cedars-Sinai Medical Center
Personalized Medicine Using iPSCs and Organs-on-Chips
11:15 AM
Patrick Finn, Twist Biosciences
Rewriting DNA Synthesis
CRISPR-G-editing
11:30 AM
Jacob Corn, UC Berkeley
Gene Correction with CRISPR-Cas9
Immune Cell Therapy
11:45 AM
David Martin, AvidBiotics
MicAbody™ Proteins Engage NK- and T-Cells
12:00 PM
Lunch, Exhibition & Networking
New Approaches
in Cancer Dx
1:00 PM
Marc Grodman, BioReference Laboratories A New Model of Clinical Genomics Collaboration
1:15 PM
Anne-Renee Hartman, Myriad
Integrated Genomic Platform for Companion Diagnostics
1:30 PM
Eric Rowinsky, Mitra Biotech
Systems Biology Approach to Predicting Response to Cancer Therapeutics
1:45 PM
Josh Stahl, ArcherDx
Complex Variant Detection Using Anchored Multiplex PCR
New Ways in Profiling Cancer
2:00 PM
Hawazin Faruki,
Genecentric
Genomic Tumor Proflling – Advancing Beyond Gene Mutations
2:15 PM
Jerry Parrott, BioMarker Strategies
Functional Profiling to Guide Cancer Drug Development and Treatment Selection
2:30 PM
Neil Campbell, Helomics
Comprehensive Tumor Profiling: Its more than Genes
2:45 PM
Russell Garlick, SeraCare Life Sciences
NGS Presents New Quality Control Challenges
3:00 PM
Break, Exhibition & Networking
3:30 PM
Closing
TRACK 4
Podium Present.
Next Generation Tools
8:45 AM
Fred Streitz, LLNL
Towards Predictive Biology with Extreme Scale Computing
9:00 AM
Bharath Takulapalli, INanoBio
Developing High Accuracy Nanopore Sequencer for $100 Genome
9:15 AM
Peter Pmaneus, Imec
Miniaturized Instrumentation to Enable Personalized Medicine
Pathogen Dx
9:30 AM
Leo McHugh, Immunexpress
Infectious Disease Diagnosis Using SeptiCyte® Gene Sign.
9:45 AM
Charles Chiu, UCSF
Genomic Approaches for Pathogen and Infectious Disease Diagnosis
10:00 AM
Break, Exhibition & Networking
Genomic Centers
10:30 AM
Ketan Paranjape, Intel
Opening words by session chair
10:45 AM
Patricia Kovatch, Icahn School of Medicine at Mount Sinai
11:00 AM
Tim Cutts, Sanger Inst.
11:15 AM
Chris Dwan, Broad Inst.
11:30 AM
Mark Beggs, Stratified Medicine Scotland
Engaging a Country for Precision Medicine
11:45 AM
John Witte, UCSF Institute for Human Genetics
12:00 PM
Lunch, Exhibition & Networking
Sequencing Platforms
1:00 PM
Jonas Korlach, PacBio
Whole Genome? The Future of High-Quality, De Novo Human Genomes
Clinically Useful Genome Interpretation
1:30 PM
Edmund Tai, PAMF
Germline Testing for Hereditary Cancer
1:45 PM
Nathan Pearson, NYGC
Why We Should Classify Genotypes, Not Variants
2:00 PM
Panel
Unlocking Data to Advance PM
2:15 PM
Pek Lum, Capella Bio
Precise Medicines from Data
2:30 PM
Bryce Olson, Intel
Collaborative Cancer Care: Unlocking Data
2:45 PM
Panel
3:00 PM
Break, Exhibition & Networking
Petabyte Scale Genomics:
Using Big Metal to Study Big Cohorts
4:00 PM
Frank Austin Nothaft, UC Berkeley AMPLab
4:15 AM
Cuiping Pan, VA Palo Alto
4:30 PM
Mike Lin, DNAnexus
4:45 PM
Uri Laserson, Cloudera
5:00 PM
Closing
Program / Day3
January 27
TRACK 1
7:00 AM
Registration, Breakfast and Networking
The Give and Take Between
Government & Personalized Medicine
8:00 AM
Kathy Hudson, NIH
The President’s Precision Medicine Initiative®
8:15 AM
Atul Butte, UCSF
The Give and Take Between
Government & Personalized Medicine
8:30 AM
Elizabeth Baca, Governor Jerry Brown’s Office of Planning and Research (OPR)
The Observation of Accelerated Transformation of Biomedicine
8:45 AM
Keith Yamamoto, UCSF
Precision Medicine: Beyond The Inflection Point
Patient-centered Drug Development
9:00 AM
Stephan Brock, Molecular Health
Clinical Innovation Using Outcomes Data
9:15 AM
Mark L. Watson, Guardian Research Network
Re-Engineering The US Clinical Trials System
9:30 AM
Alan Wu, UCSF
Promoting Pharmacogenomics to the Public
9:45 AM
Panel
10:00 AM
Break, Exhibition & Networking
New Drug Discovery in Oncology: Faster, Cheaper, Better
10:30 AM
George Sledge, Stanford
Opening words by session chair
10:45 AM
Gideon Blumenthal, FDA
Expediting Development of Oncology Drugs
11:00 AM
August Salvado, Novartis
Signature: Designed to Find the Right Patient
11:15 AM
Panel
Personalized Medicine Patent Law Update
11:30 AM
Catherine Polizzi, Morrison & Foerster
Michael Shuster, Fenwick & West
12:00 PM
Q&A
12:15 PM
Lunch, Exhibition & Networking
Expansion of Non-Invasive Prenatal Testing
1:00 PM
Kimberly Martin, Natera
Opening by session chair
1:15 PM
Peter Benn, UConn Health
Non-invasive Testing for Low-risk Women
1:30 PM
Anthony Gregg, UF
Disruption the Nidus for Practice Guideline Development
1:45 PM
Panel
The Microbiome- A Modifiable Biomarker?
2:00 PM
Ami Bhatt, Stanford
Opening words by session chair
2:15 PM
Peter DiLaura, Second Genome
Exploring the Microbiome for Novel Therapeutics
2:30 PM
David Cook, Seres Therapeutics
Microbiome Therapeutics in The Age of Personalized DNA
Sequence
2:45 PM
Panel
3:00 PM
Break, Exhibition & Networking
Changing the
Point Of Care Setting
3:30 PM
Charles Chiu, UCSF
Changing the Point-of-Care Setting for Precision Medicine in Infectious Diseases
4:00PM
Closing
TRACK 2
8:15 AM
Mara Aspinall, GenePeeks
The Role of Algorithms in Clinical Diagnostics
Large-scale Genomics Projects
8:30 AM
David Ledbetter, Geisinger
Geisinger’s Precision Health Initiative
8:45AM
Peter Donnelly, Oxford University
Using Genetics to Improve Healthcare
9:00 AM
Andrew Carroll, DNAnexus
Genomics in the Next Five Years
9:15 AM
Hannes Smarason, WuXi NextCODE
Delivering Precision Medicine Worldwide Today
9:30 AM
Catherine Ball, Ancestry
Genomic Data, Migration Patterns & Disease
9:40 AM
Panel
10:00 AM
Break, Exhibition & Networking
Large Scale Sequencing and Analysis
10:30 AM
David Glazer, Google
Opening words by session chair
10:45 AM
Jurgi Camblong, Sophia Genetics
Towards Data Driven Medicine:
Europe Shows the Way
11:00 AM
Devin Locke,
Seven Bridges Genomics
Discovery in Millions of Genomes
11:15 AM
Panel
Consumer Genomics
11:30 AM
Justin Kao, Helix
Helix: A New Approach to Consumer Genomics
11:45 AM
Break
12:00 PM
Lunch, Exhibition & Networking
Expediting Genomics into the Clinic
1:00 PM
Lincoln Nadauld, Intermountain Healthcare
Opening words by session chair
1:15 PM
Sherri Millis, Ashion Analytics
Go Big or Go Home
1:30 PM
James Ford, Stanford
Implementing a Clinical Cancer Genomics Program
1:45 PM
Panel
Producing Clinical Actionable Reports
2:00 PM
Sean Sigmon, Oracle
Scaling & Enhancing PM Reporting
2:15 PM
Don Rule, Translational Software
Big Data to Actionable Reports
2:30 PM
Shaun Opie, Vantari Genetics
Bootstrapping Clinically Actionable Reports
2:45 PM
Panel
3:00 PM
Break, Exhibition & Networking
Early Cancer Detection: A new Hope
3:30PM
Raghu Kalluri,
MD Anderson
Utility Of Exosomes in the Detection of Cancer
4:00PM
Closing
TRACK 3
Genomics Offered As-a-Service
9:45 AM
Taylor Sittler, Color Genomics
Responsible Genetic Testing at Color Genomics
10:00 AM
Break, Exhibition & Networking
Precision Medicine in the Clinical Workflow
10:30 AM
Assaf Halevy, Allscripts
Precision Medicine in the Clinical Workflow
10:45 AM
Mark Harris, NextGxDx
Efficiency and Transparency in Genetic Diagnostics
Innovation Advances in NIPT
11:00 AM
Gautam Kollu, Illumina
Innovative Advances in Non-Invasive Prenatal Testing
11:15 AM
Mathias Ehrich, Sequenom
Expanding NIPT to the Whole Genome
11:30 AM
Lee Shulman, Northwestern University
CCFNA: Improving Prenatal Screening & Beyond
11:45 AM
Panel
12:00 PM
Lunch, Exhibition & Networking
Carrier and Hereditary Disease Testing
1:00 PM
Ramji Srinivasan, Counsyl
Opening by session chair
Panel:
Emily Rapp Black, Patient
Ruth Bunker Lathi, Stanford
Ramji Srinivasan, Counsyl
Carrier and Hereditary Disease Testing- Cont.
2:00 PM
Tero-Pekka Alastalo, Blueprint Genetics Inc.
OS-Seq Boosting Genetic Diagnostics
2:15 PM
Alexander Bisignano, Recombine
Powering Research Through the Clinic
Obesity & Diabetes
2:30 PM
Robert Lustig, UCSF
Genes & Environment in Metabolic Disease
2:45 PM
Ruth March, Astra Zeneca
Personalised Healthcare in Metabolic Disease
3:00 PM
Break, Exhibition & Networking
3:30 PM
Closing
